Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Neonatal Medicine

Anemia Management

Iron supplementation enhances response to dose of recombinant human erythropoietin in preterm infants.

Carnielli VP, Da Riol R, Montini G.

Source‎: Arch Dis Child Fetal Neonatal Ed 1998;79(1):F44-8.

Indexed‎: PubMed 9797624

Early versus late enteral prophylactic iron supplementation in preterm very low birth weight infants: a randomised controlled trial.

Joy R, Krishnamurthy S, Bethou A, Rajappa M, Ananthanarayanan PH, Bhat BV.

Source‎: Arch Dis Child Fetal Neonatal Ed 2014;99(2):F105-9.

Indexed‎: PubMed 24302687

DOI‎: 10.1136/archdischild-2013-304650

Nonpharmacological, blood conservation techniques for preventing neonatal anemia—effective and promising strategies for reducing transfusion.

Carroll PD, Widness JA.

Source‎: Semin Perinatol 2012;36(4):232-43.

Indexed‎: PubMed 22818543

DOI‎: 10.1053/j.semperi.2012.04.003

Enteral iron supplementation in preterm and low birth weight infants.

Mills RJ, Davies MW.

Source‎: Cochrane Database Syst Rev 2012;(3):CD005095.

Indexed‎: PubMed 22419305

DOI‎: 10.1002/14651858.CD005095.pub2

Iron supplementation for preterm infants receiving restrictive red blood cell transfusions: reassessment of practice safety.

Arnon S, Dolfin T, Bauer S, et al.

Source‎: J Perinatol 2010;30(11):736-40.

Indexed‎: PubMed 20220759

DOI‎: 10.1038/jp.2010.33

Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.

Bierer R, Roohi M, Peceny C, Ohls RK.

Source‎: J Pediatr Surg 2009;44(8):1540-5.

Indexed‎: PubMed 19635302

DOI‎: 10.1016/j.jpedsurg.2008.10.112

Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants.

Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A.

Source‎: Pediatrics 2006;118(5):2004-13.

Indexed‎: PubMed 17079573

Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.

Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA, Lubec G, Weninger M, Widness JA.

Source‎: Pediatrics 2001;107(1):78-85.

Indexed‎: PubMed 11134438

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.